Literature DB >> 8806512

Fine mapping of a C-terminal linear epitope highly conserved among the major envelope glycoprotein E2 (gp51 to gp54) of different pestiviruses.

M Yu1, L F Wang, B J Shiell, C J Morrissy, H A Westbury.   

Abstract

Envelope glycoprotein E2 (gp51 to gp54) is the major neutralizing antigen of pestiviruses, which include classical swine fever virus (CSFV), bovine viral diarrhoea virus (BVDV), and border disease virus (BVD). Previous studies carried out using a panel of monoclonal antibodies raised against CSFV strain Brescia have revealed the existence of four antigenic domains, A to D, of the E2 protein, all of which are located at the N-terminal half of the molecule. Here we report the detailed mapping, using three complementary techniques, of a novel linear epitope located at the C-terminal part of the molecule, which reacted with a monoclonal antibody (4-9D4) as well as polyclonal animal sera. This epitope is highly conserved in the three different members of pestiviruses and hence can be used as a genus-specific diagnosis tool. The observation that this epitope is not accessible on the native virus surface, together with its C-terminal location, supports a recently proposed structural model, indicating that the C-terminal part of E2 is membrane-bound while the N-terminal half of the molecule is exposed on the virus surface.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806512     DOI: 10.1006/viro.1996.0423

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Deletions of structural glycoprotein E2 of classical swine fever virus strain alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum.

Authors:  M Lin; F Lin; M Mallory; A Clavijo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Genome comparison of a novel classical swine fever virus isolated in China in 2004 with other CSFV strains.

Authors:  Xiangmin Li; Zhuofei Xu; Yannan He; Qinxia Yao; Keshan Zhang; Meilin Jin; Huanchun Chen; Ping Qian
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates.

Authors:  Antonino S Cavallaro; Donna Mahony; Margaret Commins; Timothy J Mahony; Neena Mitter
Journal:  Microb Cell Fact       Date:  2011-07-26       Impact factor: 5.328

4.  Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.

Authors:  Bin Zhou; Ke Liu; Yan Jiang; Jian-Chao Wei; Pu-Yan Chen
Journal:  Virol J       Date:  2011-07-30       Impact factor: 4.099

Review 5.  Structures and Functions of Pestivirus Glycoproteins: Not Simply Surface Matters.

Authors:  Fun-In Wang; Ming-Chung Deng; Yu-Liang Huang; Chia-Yi Chang
Journal:  Viruses       Date:  2015-06-29       Impact factor: 5.048

6.  Identification of a Common Conformational Epitope on the Glycoprotein E2 of Classical Swine Fever Virus and Border Disease Virus.

Authors:  Yu-Liang Huang; Denise Meyer; Alexander Postel; Kuo-Jung Tsai; Hsin-Meng Liu; Chia-Huei Yang; Yu-Chun Huang; Nicholas Berkley; Ming-Chung Deng; Fun-In Wang; Paul Becher; Helen Crooke; Chia-Yi Chang
Journal:  Viruses       Date:  2021-08-20       Impact factor: 5.048

7.  A β-Hairpin Motif in the Envelope Protein E2 Mediates Receptor Binding of Bovine Viral Diarrhea Virus.

Authors:  Fernando Merwaiss; María José Pascual; María Trinidad Pomilio; María Gabriela Lopez; Oscar A Taboga; Diego E Alvarez
Journal:  Viruses       Date:  2021-06-17       Impact factor: 5.048

8.  Improvement of a recombinant antibody-based serological assay for foot-and-mouth disease virus.

Authors:  Janine D Muller; Michelle Wilkins; Adam J Foord; Olan Dolezal; Meng Yu; Hans G Heine; Lin-Fa Wang
Journal:  J Immunol Methods       Date:  2009-11-11       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.